Cargando…

Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network

Alzheimer's disease (AD) is known as a critical neurodegenerative disorder. It worsens as symptoms concerning dementia grow severe over the years. Due to the globalization of Alzheimer's disease, its prevention and treatment are vital. This study proposes a method to extract substantial ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soleimani Zakeri, Negar Sadat, Pashazadeh, Saeid, MotieGhader, Habib
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531773/ https://www.ncbi.nlm.nih.gov/pubmed/34692825 http://dx.doi.org/10.1155/2021/1280237

Ejemplares similares

Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach
por: Soleimani Zakeri, Negar Sadat, et al.
Publicado: (2020)

Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis
por: Adhami, Masoumeh, et al.
Publicado: (2021)

Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis
por: MotieGhader, Habib, et al.
Publicado: (2021)

Application of Protein-Protein Interaction Network Analysis in Order to Identify Cervical Cancer miRNA and mRNA Biomarkers
por: Tabrizi-Nezhadi, Parinaz, et al.
Publicado: (2023)

mRNA–miRNA bipartite networks reconstruction in different tissues of bladder cancer based on gene co-expression network analysis
por: Abedi, Zahra, et al.
Publicado: (2022)

Sequential and Mixed Genetic Algorithm and Learning Automata (SGALA, MGALA) for Feature Selection in QSAR
por: MotieGhader, Habib, et al.
Publicado: (2017)

Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug–gene interaction networks analysis
por: MotieGhader, Habib, et al.
Publicado: (2022)

Drug Repurposing by Simulating Flow Through Protein–Protein Interaction Networks
por: Manczinger, M, et al.
Publicado: (2017)

Network-based stage-specific drug repurposing for Alzheimer’s disease
por: Savva, Kyriaki, et al.
Publicado: (2022)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease
por: Kumar, Shivani, et al.
Publicado: (2017)

Exploiting large-scale drug-protein interaction information for computational drug repurposing
por: Liu, Ruifeng, et al.
Publicado: (2014)

Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing
por: Sagulkoo, Pakorn, et al.
Publicado: (2022)

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
por: Araki, Wataru
Publicado: (2013)

Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2020)

Repurposing Licensed Drugs for Use Against Alzheimer’s Disease
por: Norins, Leslie C.
Publicado: (2021)

Single-cell-led drug repurposing for Alzheimer’s disease
por: Parolo, Silvia, et al.
Publicado: (2023)

A Comparative Study of Cluster Detection Algorithms in Protein–Protein Interaction for Drug Target Discovery and Drug Repurposing
por: Ma, Jun, et al.
Publicado: (2019)

Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
por: Yarchoan, Mark, et al.
Publicado: (2014)

Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
por: Rodriguez, Steve, et al.
Publicado: (2021)

Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
por: Ancidoni, Antonio, et al.
Publicado: (2021)

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2023)

Modeling Path Importance for Effective Alzheimer’s Disease Drug Repurposing
por: Xiang, Shunian, et al.
Publicado: (2023)

Repurposing of Tibolone in Alzheimer’s Disease
por: Barreto, George E.
Publicado: (2023)

Drug repurposing with network reinforcement
por: Nam, Yonghyun, et al.
Publicado: (2019)

Drug Repurposing Using Modularity Clustering in Drug-Drug Similarity Networks Based on Drug–Gene Interactions
por: Groza, Vlad, et al.
Publicado: (2021)

Systematic identification of risk factors and drug repurposing options for Alzheimer's disease
por: Wu, Chong, et al.
Publicado: (2021)

Drug repurposing using meta-analysis of gene expression in Alzheimer’s disease
por: Jang, Ha Young, et al.
Publicado: (2022)

Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood
por: Bourdakou, Marilena M., et al.
Publicado: (2023)

A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing
por: Gordon, David E., et al.
Publicado: (2020)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Comparative analysis of protein-protein interaction networks in metastatic breast cancer
por: Hozhabri, Hossein, et al.
Publicado: (2022)

Protein interaction network for Alzheimer's disease using computational approach
por: Rao, V Srinivasa, et al.
Publicado: (2013)

Hybrid neural network approaches to predict drug–target binding affinity for drug repurposing: screening for potential leads for Alzheimer’s disease
por: Wu, Xialin, et al.
Publicado: (2023)

Clustering drug-drug interaction networks with energy model layouts: community analysis and drug repurposing
por: Udrescu, Lucreţia, et al.
Publicado: (2016)

Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy
por: Chumakov, Ilya, et al.
Publicado: (2015)

Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study
por: Walker, Venexia M, et al.
Publicado: (2019)

Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer’s Disease: Using the Multiomics Approach
por: Advani, Dia, et al.
Publicado: (2021)

Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
por: Fang, Jiansong, et al.
Publicado: (2022)

Identification of Potential Repurposable Drugs in Alzheimer’s Disease Exploiting a Bioinformatics Analysis
por: Fiscon, Giulia, et al.
Publicado: (2022)

Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer’s Disease
por: Savva, Kyriaki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nddf2h8po46nonn1vkbh7187no